Company
Integra
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
47
510(k), De Novo and PMA
Device trials
70
As lead sponsor, any status
Adverse event reports
857
Received Nov 1, 2025 to Nov 19, 2026
Recall records
430
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Integra, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Integra.
Latest FDA decisions
The 8 newest of 47 since 2015.
K261004 · Decided Jun 23, 2026 · 89 days after receipt
Device type: Shunt, Central Nervous System And Components (JXG) · Neurology & Neurosurgery
K251162 · Decided Oct 8, 2025 · 176 days after receipt
Device type: Instrument, Ultrasonic Surgical (LFL) · General & Plastic Surgery
K243531 · Decided Aug 8, 2025 · 267 days after receipt
Device type: Shunt, Central Nervous System And Components (JXG) · Neurology & Neurosurgery
44 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Urinary Bladder Matrix (UBM) RegistryNot yet recruiting
NCT07805798 · 300 participants (planned) · Start Aug 31, 2026 · Primary completion Aug 31, 2029
Device: Urinary Bladder Matrix (UBM) Products · For: Tissue Repair; Soft Tissue Reconstruction; Wound Management and 8 more
- A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg UlcersPivotal-lookingEnrolling by invitation
NCT06453187 · 350 participants (planned) · Start Nov 18, 2024 · Primary completion Dec 31, 2026
Device: Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers; Urinary Bladder Matrix (UBM) sheet device for Diabetic Foot Ulcers and 2 more · For: Diabetic Foot Ulcer; Venous Leg Ulcer
Sites: Los Angeles, California; San Francisco, California; Vista, California · 13 sites in all
NCT06629506 · 25 participants · Start Dec 12, 2024 · Primary completion Aug 31, 2025
Device: MicroMatrix® Flex; MicroMatrix® UBM Particulate and 1 more · For: Pressure Injury; Venous Ulcer; Necrotizing Soft Tissue Infection and 2 more
Sites: Aurora, Colorado; Washington D.C., District of Columbia; Lake Success, New York
67 more trials with a free account
Reports received
857
Received Nov 1, 2025 to Nov 19, 2026. Includes 35 of another or unstated type.
Malfunction reports
442
52% of reports
Injury reports
377
44% of reports
Death reports
3
0.4% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 37 | 50 | 2 | 2 |
| Jan 24 | 71 | 39 | 0 | 0 |
| Feb 24 | 57 | 54 | 0 | 0 |
| Mar 24 | 46 | 57 | 0 | 0 |
| Apr 24 | 54 | 47 | 0 | 0 |
| May 24 | 54 | 58 | 0 | 0 |
| Jun 24 | 71 | 43 | 0 | 0 |
| Jul 24 | 50 | 41 | 1 | 0 |
| Aug 24 | 64 | 57 | 0 | 0 |
| Sep 24 | 47 | 47 | 2 | 0 |
| Oct 24 | 40 | 56 | 0 | 0 |
| Nov 24 | 62 | 36 | 0 | 0 |
| Dec 24 | 52 | 38 | 0 | 0 |
| Jan 25 | 58 | 37 | 0 | 0 |
| Feb 25 | 58 | 41 | 2 | 0 |
| Mar 25 | 56 | 36 | 1 | 0 |
| Apr 25 | 48 | 41 | 2 | 0 |
| May 25 | 67 | 52 | 0 | 0 |
| Jun 25 | 35 | 66 | 0 | 0 |
| Jul 25 | 72 | 57 | 0 | 0 |
| Aug 25 | 39 | 44 | 0 | 0 |
| Sep 25 | 59 | 22 | 0 | 0 |
| Oct 25 | 53 | 48 | 0 | 0 |
| Nov 25 | 37 | 20 | 0 | 0 |
| Dec 25 | 39 | 28 | 2 | 0 |
| Jan 26 | 25 | 33 | 0 | 0 |
| Feb 26 | 43 | 50 | 0 | 0 |
| Mar 26 | 50 | 36 | 1 | 0 |
| Apr 26 | 29 | 28 | 0 | 0 |
| May 26 | 53 | 38 | 0 | 0 |
| Jun 26 | 25 | 33 | 0 | 0 |
| Jul 26 | 35 | 27 | 0 | 9 |
| Aug 26 | 33 | 36 | 0 | 14 |
| Sep 26 | 32 | 29 | 0 | 6 |
| Oct 26 | 41 | 19 | 0 | 6 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- OmniTract Surgical Retractor System, which includes 633 of the firm s product codes.Open, Classified
Z-2714-2026 · Started Jun 5, 2026 · Posted by FDA Jul 9, 2026
Reason given: The current Omni-Tract Surgical Retractor System IFU states a dry time of 30 minutes. Integra LifeSciences has identified that the dry time needs to be extended to 90 minutes, 110 minutes, or 120 minutes depending on the sterilization cycle exposure time used.
Cause as FDA categorized it: Labeling design · Device type: Retractor (GAD)
Z-2173-2026 · Started Apr 10, 2026 · Posted by FDA May 13, 2026
Reason given: Out-of-specification endotoxin result that did not meet the acceptance criteria.
Cause as FDA categorized it: Process control · Device type: Shunt, Central Nervous System And Components (JXG)
- Cytal Wound Matrix 2-Layer 5x5 cm. Product ID: WSM0505.Open, Classified
Z-1816-2026 · Started Mar 19, 2026 · Posted by FDA Apr 15, 2026
Reason given: Increased rate of out-of-specification endotoxin results.
Cause as FDA categorized it: Under Investigation by firm · Device type: Wound Dressing With Animal-Derived Material(S) (KGN)
427 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.